OBJECTIVE: This study examines whether overweight in midlife increases dementia risk later in life. METHODS: In 1963 body mass index was assessed in 1152 participants of The Swedish Twin Registry, at the age of 45-65 years. These participants were later screened for dementia in a prospective study with up to 40 years follow-up. A total of 312 participants were diagnosed with dementia. RESULTS: Logistic regression analyses adjusted for demographic factors, smoking and alcohol habits, indicated that men and women categorized as overweight in their midlife had an elevated risk of dementia (OR=1.59; 95% CI: 1.21-2.07, P=0.002), Alzheimer's disease (OR=1.71; 95% CI: 1.24-2.35, P=0.003), and vascular dementia (OR=1.55; 95% CI: 0.98-2.47, P=0.059). Further adjustments for diabetes and vascular diseases did not substantially affect the associations, except for vascular dementia (OR=1.36; 95% CI: 0.82-2.56, P=0.116), reflecting the significance of diabetes and vascular diseases in the etiology of vascular dementia. There was no significant interaction between overweight and APOE epsilon4 status, indicating that having both risk factors does not have a multiplicative effect with regard to dementia risk. CONCLUSIONS: This study gives further support to the notion that overweight in midlife increases later risk of dementia. The risk is increased for both Alzheimer's disease and vascular dementia, and follows the same pattern for men and women.
OBJECTIVE: This study examines whether overweight in midlife increases dementia risk later in life. METHODS: In 1963 body mass index was assessed in 1152 participants of The Swedish Twin Registry, at the age of 45-65 years. These participants were later screened for dementia in a prospective study with up to 40 years follow-up. A total of 312 participants were diagnosed with dementia. RESULTS: Logistic regression analyses adjusted for demographic factors, smoking and alcohol habits, indicated that men and women categorized as overweight in their midlife had an elevated risk of dementia (OR=1.59; 95% CI: 1.21-2.07, P=0.002), Alzheimer's disease (OR=1.71; 95% CI: 1.24-2.35, P=0.003), and vascular dementia (OR=1.55; 95% CI: 0.98-2.47, P=0.059). Further adjustments for diabetes and vascular diseases did not substantially affect the associations, except for vascular dementia (OR=1.36; 95% CI: 0.82-2.56, P=0.116), reflecting the significance of diabetes and vascular diseases in the etiology of vascular dementia. There was no significant interaction between overweight and APOE epsilon4 status, indicating that having both risk factors does not have a multiplicative effect with regard to dementia risk. CONCLUSIONS: This study gives further support to the notion that overweight in midlife increases later risk of dementia. The risk is increased for both Alzheimer's disease and vascular dementia, and follows the same pattern for men and women.
Authors: Paul Lichtenstein; Patrick F Sullivan; Sven Cnattingius; Margaret Gatz; Sofie Johansson; Eva Carlström; Camilla Björk; Magnus Svartengren; Alicja Wolk; Lars Klareskog; Ulf de Faire; Martin Schalling; Juni Palmgren; Nancy L Pedersen Journal: Twin Res Hum Genet Date: 2006-12 Impact factor: 1.587
Authors: Rachel A Whitmer; Erica P Gunderson; Charles P Quesenberry; Jufen Zhou; Kristine Yaffe Journal: Curr Alzheimer Res Date: 2007-04 Impact factor: 3.498
Authors: May A Beydoun; April Lhotsky; Youfa Wang; Gloria Dal Forno; Yang An; E Jeffrey Metter; Luigi Ferrucci; Richard O'Brien; Alan B Zonderman Journal: Am J Epidemiol Date: 2008-10-03 Impact factor: 4.897
Authors: Michael L Alosco; Mary Beth Spitznagel; Gladys Strain; Michael Devlin; Ronald Cohen; Robert Paul; Ross D Crosby; James E Mitchell; John Gunstad Journal: Obesity (Silver Spring) Date: 2013-10-15 Impact factor: 5.002
Authors: Michael L Alosco; Rachel Galioto; Mary Beth Spitznagel; Gladys Strain; Michael Devlin; Ronald Cohen; Ross D Crosby; James E Mitchell; John Gunstad Journal: Am J Surg Date: 2013-10-10 Impact factor: 2.565
Authors: Y-F Chuang; Y An; M Bilgel; D F Wong; J C Troncoso; R J O'Brien; J C Breitner; L Ferruci; S M Resnick; M Thambisetty Journal: Mol Psychiatry Date: 2015-09-01 Impact factor: 15.992